The short answer: semaglutide wins on weight loss, metformin wins on cost
Semaglutide produces dramatically more weight loss than metformin — roughly 15% of body weight versus 3–5% for metformin. There's no clinical question about which is more effective for weight loss. The comparison is relevant because metformin is frequently prescribed first, is extremely cheap, and is familiar to most physicians. Understanding what each does — and doesn't do — helps you have a better conversation with your provider.
Metformin
- Average weight loss: 3–5% body weight
- Mechanism: reduces liver glucose production, improves insulin sensitivity
- Approved for type 2 diabetes — off-label for weight loss
- Cost: $4–15/month generic
- Decades of safety data
- Oral pill — no injection
- First-line diabetes medication worldwide
Semaglutide
- Average weight loss: ~15% body weight
- Mechanism: GLP-1 receptor agonist, suppresses appetite at brain level
- Approved for diabetes (Ozempic) and weight loss (Wegovy)
- Cost: $99–$249/month compounded, $900–$1,100 brand-name
- Several years of post-market safety data
- Weekly subcutaneous injection
- 3–5x more weight loss than metformin
How they work differently
Metformin primarily works in the liver — reducing the liver's glucose output and improving how cells respond to insulin. It has modest effects on appetite and weight that are secondary to its metabolic action. The weight loss from metformin is real but modest, averaging 3–5 kg (7–11 lbs) over 12 months in clinical studies.
Semaglutide works primarily in the brain and gut — mimicking the GLP-1 hormone to directly suppress appetite, reduce cravings, slow gastric emptying, and improve insulin signaling. Weight loss from semaglutide comes primarily from eating less, not just from better insulin utilization. This is why the results are so dramatically different despite both drugs affecting insulin metabolism.
Head-to-head comparison
| Factor | Metformin | Semaglutide |
|---|---|---|
| Average weight loss | ~3–5% body weight | ~15% body weight |
| Primary mechanism | Insulin sensitizer | Appetite suppression + insulin |
| Monthly cost (generic/compounded) | $4–15 | $99–$249 (compounded) |
| Administration | Oral pill | Weekly injection |
| Years of data | 50+ years | ~8 years |
| Cardiovascular benefit | Yes (established) | Yes (SELECT trial) |
| PCOS benefit | Yes — first-line | Yes — strong |
| Primary side effects | GI (nausea, diarrhea) | GI (nausea, vomiting) |
| Insurance coverage | Universal — very cheap generic | Limited for weight loss |
When metformin makes sense over semaglutide
- Cost is the primary constraint: At $4–15/month, metformin is accessible to virtually everyone. If the goal is meaningful but modest weight loss with maximum affordability, metformin is a legitimate starting point
- Needle aversion is significant: Metformin is an oral pill. For patients with strong aversion to injections who can't tolerate the idea of weekly self-injection, metformin provides some benefit without the injection barrier
- PCOS management: Metformin is the established first-line treatment for PCOS-related insulin resistance and is extremely well-studied in this context. It's frequently prescribed alongside GLP-1 therapy for PCOS, not instead of it
- Physician preference for established medications: Many primary care physicians are more comfortable prescribing metformin for weight-related concerns than newer GLP-1 medications. If your doctor recommends starting there, it's not unreasonable to try
When semaglutide makes sense over metformin
For patients whose primary goal is meaningful weight loss — not just modest metabolic improvement — semaglutide is the clear clinical choice. The 3–5x difference in weight loss outcomes is clinically significant. Metformin producing 3–5% weight loss versus semaglutide's 15% isn't a close comparison when substantial weight loss is the goal.
If you've already tried metformin for weight management and achieved limited results, this is exactly the situation where moving to a GLP-1 medication makes clinical sense. Many patients transition from metformin to semaglutide (or add semaglutide to existing metformin) when their weight loss goals require more than metformin can deliver.
Ready to try semaglutide?
Compounded semaglutide through DirectMeds starts at ~$99/month — the same active molecule as Ozempic at a fraction of the brand-name cost.
Check eligibility at DirectMeds →